Even as the Congress leadership is boggled with its Karnataka conundrum, reports indicate that the party may end up with the ...
Fuel removal began in September 2022. Defueling of reactor 4 started 2022 and took 24 months. Defueling of reactor 3 started ...
The UK's Office for Nuclear Regulation has granted the Hinkley Point B nuclear power plant in Somerset Fuel Free Verification ...
Why Oculis Holding (OCS) Is Up 15.3% After FDA Breakthrough Status For Privosegtor In Optic Neuritis
Oculis Holding AG recently reported that its neuroprotective candidate Privosegtor received U.S. FDA Breakthrough Therapy ...
India Today on MSN
TN BJP state secretary slams DMK-Congress alliance, predicts NDA victory in 2026 elections
On this special report, Tamil Nadu BJP State Secretary Vinoj P. Selvam launches a scathing attack on the ruling DMK and its ...
The nation is gripped by the goings on in the new series of The Traitors - and now the ten rules have been revealed which cannot be broken on the hit BBC show ...
Rumors of Defection Among Congress Legislators In Bihar, there are growing rumors that all six Congress legislators may join ...
Assam and the North-East have always contributed bravehearts to the nation. From gallantry award winners to senior commanders ...
Mr Muralidhar’s contention cannot be dismissed; but an assessment of the court’s agility cannot be based on the perception of ...
Nearly eight months after he expelled his elder son, Tej Pratap Yadav, from the party over a Facebook post, Rashtriya Janata ...
Detailed price information for Bridgebio Pharma Inc (BBIO-Q) from The Globe and Mail including charting and trades.
The FDA is expected to decide on treatments for allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results